心臓マーカーの世界市場レポート 2025年

心臓マーカーの市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）13.0％で203億5,000万米ドルに成長します。予測期間の成長は、生活習慣病の負担増、遠隔モニタリングと遠隔医療、個別化医療と精密診断、ポイントオブケア検査（POCT）の採用、ヘルスケアにおけるコラボレーションとパートナーシップに起因しています。予測期間の主な動向には、バイオマーカーの発見と検証、個別化医療アプローチ、アッセイプラットフォームの技術進歩、高感度トロポニン検査の統合、心血管疾患有病率の上昇などが含まれます。

心臓マーカー市場の急拡大は、心疾患の有病率の上昇に強く牽引されていると予測されます。このカテゴリーには、心臓の構造や機能に影響を及ぼす病態が含まれ、さまざまな医学的問題につながります。心臓マーカーは、心臓発作、狭心症、心不全、その他の心血管系疾患など、さまざまな心臓関連疾患の診断やモニタリングに欠かせないツールです。その結果、心臓マーカーを含む診断検査の需要は顕著に増加しています。例えば、英国心臓財団は、パンデミックの発生から2022年8月までに英国で冠動脈性心臓病による死亡が30,000人増加したという驚くべき報告を行った。さらに、2022年8月までに心臓病の待機リストに載っている人は346,000人にのぼる。したがって、心臓疾患の有病率の上昇は、心臓マーカー市場の成長を大きく促進します。

診断センターにおける需要の高まりは、心臓マーカー市場の成長軌道の極めて重要な促進要因となっています。専門ヘルスケア施設である診断センターは、健康状態の特定と監視を目的としたさまざまな医療検査や処置の実施において重要な役割を果たしています。このようなセンターに心臓マーカーを組み込むことで、タイムリーで正確な診断、リスク評価、オーダーメイドの治療戦略のための重要な知見が得られ、最終的に心血管系の健康状態の改善につながります。例えば、GOV.UKによると、2022年には73の診断センターで週当たり30,000件の検査が実施され、2025年には160の地域診断センターに増加する可能性があると予測されています。その結果、診断センターにおける需要の急増が心臓マーカー市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界心臓マーカーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の心臓マーカー市場：成長率分析
• 世界の心臓マーカー市場の実績：規模と成長, 2019-2024
• 世界の心臓マーカー市場の予測：規模と成長, 2024-2029, 2034F
• 世界心臓マーカー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心臓マーカー市場バイオマーカーによる、実績と予測, 2019-2024, 2024-2029F, 2034F
• トロポニン
• クレアチンキナーゼ-MB（CK-MB）
• B型ナトリウム利尿ペプチド（BNP）
• ミオグロビン
• その他のバイオマーカー
• 世界の心臓マーカー市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬
• 機器
• 化学発光
• 免疫蛍光法
• 免疫クロマトグラフィー
• ELISA
• 世界の心臓マーカー市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心筋梗塞
• うっ血性心不全
• 急性冠症候群
• その他の適応症
• 世界の心臓マーカー市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 実験室試験施設
• 病院の検査室
• リファレンスラボ
• 契約試験ラボ
• ポイントオブケア検査施設
• 学術機関
• 世界の心臓マーカー市場トロポニンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• トロポニンI
• トロポニンT
• トロポニン診断キット
• 世界の心臓マーカー市場クレアチンキナーゼ-MB（CK-MB）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CK-MBテストキット
• CK-MB診断パネル
• 世界の心臓マーカー市場、B型ナトリウム利尿ペプチド（BNP）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• BNP検査キット
• NT-ProBNP検査キット
• BNP診断パネル
• 世界の心臓マーカー市場ミオグロビンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ミオグロビン検査キット
• ミオグロビン診断パネル
• 世界の心臓マーカー市場、その他のバイオマーカーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 虚血修飾アルブミン（IMA）
• 心臓脂肪酸結合タンパク質（HFABP）
• C反応性タンパク質（CRP）

第7章 地域別・国別分析

• 世界の心臓マーカー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の心臓マーカー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心臓マーカー市場：競合情勢
• 心臓マーカー市場：企業プロファイル
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Guangzhou Wondifo Biotech Co. Ltd.
• Creative Diagnostics
• PerkinElmer Inc.
• Tosoh Corporation
• Quidel Corporation
• Randox Laboratories Ltd.
• Getinge Group
• LSI Medience Corporation
• Ortho Clinical Diagnostics
• DiaSorin
• 3M Company
• Atom Medical Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 心臓マーカー市場2029：新たな機会を提供する国
• 心臓マーカー市場2029：新たな機会を提供するセグメント
• 心臓マーカー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cardiac markers are biomolecules released into the bloodstream in response to heart muscle damage or stress, serving as crucial tools for diagnosing and monitoring a spectrum of cardiac ailments such as heart attacks, angina, and heart failure.

The primary types of cardiac markers encompass troponin, creatine kinase-MB (CK-MB), B-type natriuretic peptide (BNP), myoglobin, and various other biomarkers. Troponin, a protein released upon heart muscle damage, stands as a pivotal marker widely used for diagnosing and monitoring heart-related conditions. Diverse products in the realm of cardiac markers include reagents, instruments, and various detection methodologies such as chemiluminescence, immunofluorescence, immunochromatography, and ELISA. These markers find application across multiple indications, including myocardial infarction, congestive heart failure, acute coronary syndrome, among others. End users encompass laboratory testing facilities, hospital labs, reference labs, contract testing labs, point-of-care testing facilities, and academic institutions, where these markers play a vital role in cardiac diagnostics and monitoring.

The cardiac marker market research report is one of a series of new reports from The Business Research Company that provides Cardiac marker market statistics, including global market size, regional shares, competitors with a cardiac marker market share, detailed cardiac marker market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker industry. This cardiac marker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac marker market size has grown rapidly in recent years. It will grow from$11.26 billion in 2024 to $12.47 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increased incidence of cardiovascular diseases, aging population and cardiovascular risk, awareness programs and health screenings, integration of biomarkers in clinical practice, stringent regulatory standards and guidelines

The cardiac marker market size is expected to see rapid growth in the next few years. It will grow to $20.35 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to rising burden of lifestyle-related diseases, remote monitoring and telemedicine, personalized medicine and precision diagnostics, point-of-care testing (poct) adoption, collaborations and partnerships in healthcare. Major trends in the forecast period include biomarker discovery and validation, personalized medicine approaches, technological advancements in assay platforms, integration of high-sensitivity troponin tests, rise in cardiovascular disease prevalence.

The projected surge in the cardiac marker market is strongly driven by the escalating prevalence of cardiac diseases. This category comprises conditions affecting the heart's structure or functionality, leading to a spectrum of medical issues. Cardiac markers serve as crucial tools in diagnosing and monitoring various heart-related conditions such as heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, the demand for diagnostic tests involving cardiac markers has seen a notable increase. For instance, the British Heart Foundation reported an alarming increase of 30,000 deaths from coronary heart disease in England from the pandemic's onset to August 2022. Moreover, a staggering 346,000 individuals were on cardiac waiting lists by August 2022. Hence, the escalating prevalence of cardiac diseases significantly fuels the growth of the cardiac marker market.

The escalating demand within diagnostic centers stands as a pivotal driver for the cardiac marker market's growth trajectory. Diagnostic centers, specialized healthcare facilities, play a crucial role in conducting a range of medical tests and procedures aimed at identifying and monitoring health conditions. The incorporation of cardiac markers in these centers offers critical insights for timely and accurate diagnoses, risk assessment, and tailored treatment strategies, ultimately leading to improved cardiovascular health outcomes. For instance, according to GOV.UK, the year 2022 witnessed 73 diagnostic centers conducting an additional 30,000 tests per week, with projections suggesting a potential increase to 160 community diagnostic centers by 2025. Consequently, the surging demand within diagnostic centers is steering the growth of the cardiac marker market.

Innovation emerges as a significant trend gaining traction within the cardiac marker market, with major players focusing on pioneering solutions to fortify their market presence. For example, MiRxes, a Singapore-based biotechnology firm, recently validated a microRNA-based diagnostic test designed for early detection and diagnosis of illnesses. The forthcoming commercialization of this test will complement MiRxes' portfolio of blood tests for various conditions, aiming to alleviate the mounting clinical and socioeconomic burdens associated with life-threatening diseases, including cancer and cardio-pulmonary disorders.

Leading companies in the cardiac marker market prioritize innovative products, such as high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers, to drive market revenue. These biomarkers play crucial roles in diagnosing, categorizing, and treating cardiovascular ailments. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a prominent China-based medical equipment and solutions provider, launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay surpasses minimal sensitivity, accuracy, and reliability requirements, aiding in identifying myocardial damage. These advanced products aim to enhance treatment approaches for cardiovascular diseases, offering dependable solutions to improve patient outcomes in both cardiovascular and related health contexts.

In April 2023, Abbott Laboratories, a US-based healthcare company acquired Cardiovascular Systems Inc. for an undisclosed amount. With this acquisition, Abbott will be able to better serve patients with peripheral and coronary artery disease by offering a novel and cutting-edge therapy for those with complicated cardiovascular disease. Through this acquisition, Abbott is able to expand the range of cutting-edge vascular devices it offers doctors, giving them more resources to assist patients. Cardiovascular Systems Inc. a US-based medical technology company.

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMerieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cardiac marker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac marker market consists of sales of C-reactive protein (CRP) and Ischemia-modified albumin (IMA). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Marker Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac marker market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac marker ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac marker market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Biomarker: Troponin; Creatine Kinase-MB (CK-MB); B-type Natriuretic Peptide (BNP); Myoglobin; Other Biomarkers
• 2) By Product: Reagent; Instrument; Chemiluminescence; Immunofluorescence; Immunochromatography; ELISA
• 3) By Indication: Myocardial Infarction; Congestive Heart Failure; Acute Coronary Syndrome; Other Indications
• 4) By End User: Laboratory Testing Facilities; Hospital Labs; Reference Labs; Contract Testing Labs; Point-Of-Care Testing Facilities; Academic Institutions
• Subsegments:
• 1) By Troponin: Troponin I; Troponin T; Troponin Diagnostic Kits
• 2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits; CK-MB Diagnostic Panels
• 3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits; NT-ProBNP Test Kits; BNP Diagnostic Panels
• 4) By Myoglobin: Myoglobin Test Kits; Myoglobin Diagnostic Panels
• 5) By Other Biomarkers: Ischemia Modified Albumin (IMA); Heart Fatty Acid Binding Protein (HFABP); C-Reactive Protein (CRP)
• Companies Mentioned: Abbott Laboratories Inc.; Siemens AG; Danaher Corporation; BioMerieux SA; F. Hoffmann-La Roche AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Marker Market Characteristics

3. Cardiac Marker Market Trends And Strategies

4. Cardiac Marker Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Cardiac Marker Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiac Marker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiac Marker Market Growth Rate Analysis
• 5.4. Global Cardiac Marker Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiac Marker Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiac Marker Total Addressable Market (TAM)

6. Cardiac Marker Market Segmentation

• 6.1. Global Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Troponin
• Creatine Kinase-MB (CK-MB)
• B-type Natriuretic Peptide (BNP)
• Myoglobin
• Other Biomarkers
• 6.2. Global Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagent
• Instrument
• Chemiluminescence
• Immunofluorescence
• Immunochromatography
• ELISA
• 6.3. Global Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Other Indications
• 6.4. Global Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing Facilities
• Hospital Labs
• Reference Labs
• Contract Testing Labs
• Point-Of-Care Testing Facilities
• Academic Institutions
• 6.5. Global Cardiac Marker Market, Sub-Segmentation Of Troponin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Troponin I
• Troponin T
• Troponin Diagnostic Kits
• 6.6. Global Cardiac Marker Market, Sub-Segmentation Of Creatine Kinase-MB (CK-MB), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CK-MB Test Kits
• CK-MB Diagnostic Panels
• 6.7. Global Cardiac Marker Market, Sub-Segmentation Of B-Type Natriuretic Peptide (BNP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• BNP Test Kits
• NT-ProBNP Test Kits
• BNP Diagnostic Panels
• 6.8. Global Cardiac Marker Market, Sub-Segmentation Of Myoglobin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myoglobin Test Kits
• Myoglobin Diagnostic Panels
• 6.9. Global Cardiac Marker Market, Sub-Segmentation Of Other Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ischemia Modified Albumin (IMA)
• Heart Fatty Acid Binding Protein (HFABP)
• C-Reactive Protein (CRP)

7. Cardiac Marker Market Regional And Country Analysis

• 7.1. Global Cardiac Marker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiac Marker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Marker Market

• 8.1. Asia-Pacific Cardiac Marker Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Marker Market

• 9.1. China Cardiac Marker Market Overview
• 9.2. China Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Marker Market

• 10.1. India Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Marker Market

• 11.1. Japan Cardiac Marker Market Overview
• 11.2. Japan Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Marker Market

• 12.1. Australia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Marker Market

• 13.1. Indonesia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Marker Market

• 14.1. South Korea Cardiac Marker Market Overview
• 14.2. South Korea Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Marker Market

• 15.1. Western Europe Cardiac Marker Market Overview
• 15.2. Western Europe Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Marker Market

• 16.1. UK Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Marker Market

• 17.1. Germany Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Marker Market

• 18.1. France Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Marker Market

• 19.1. Italy Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Marker Market

• 20.1. Spain Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Marker Market

• 21.1. Eastern Europe Cardiac Marker Market Overview
• 21.2. Eastern Europe Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Marker Market

• 22.1. Russia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Marker Market

• 23.1. North America Cardiac Marker Market Overview
• 23.2. North America Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Marker Market

• 24.1. USA Cardiac Marker Market Overview
• 24.2. USA Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Marker Market

• 25.1. Canada Cardiac Marker Market Overview
• 25.2. Canada Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Marker Market

• 26.1. South America Cardiac Marker Market Overview
• 26.2. South America Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Marker Market

• 27.1. Brazil Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Marker Market

• 28.1. Middle East Cardiac Marker Market Overview
• 28.2. Middle East Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Marker Market

• 29.1. Africa Cardiac Marker Market Overview
• 29.2. Africa Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Marker Market Competitive Landscape And Company Profiles

• 30.1. Cardiac Marker Market Competitive Landscape
• 30.2. Cardiac Marker Market Company Profiles
  • 30.2.1. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Marker Market Other Major And Innovative Companies

• 31.1. Beckman Coulter Inc.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. Guangzhou Wondifo Biotech Co. Ltd.
• 31.5. Creative Diagnostics
• 31.6. PerkinElmer Inc.
• 31.7. Tosoh Corporation
• 31.8. Quidel Corporation
• 31.9. Randox Laboratories Ltd.
• 31.10. Getinge Group
• 31.11. LSI Medience Corporation
• 31.12. Ortho Clinical Diagnostics
• 31.13. DiaSorin
• 31.14. 3M Company
• 31.15. Atom Medical Corporation

32. Global Cardiac Marker Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Marker Market

34. Recent Developments In The Cardiac Marker Market

35. Cardiac Marker Market High Potential Countries, Segments and Strategies

• 35.1 Cardiac Marker Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiac Marker Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiac Marker Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer